🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPharmacology & MechanismsGLP-1R expression map — looking for input Page 3

GLP-1R expression map — looking for input

HealthEcon_DC Mon, Jun 23, 2025 at 1:00 PM 13 replies 1,471 viewsPage 3 of 3
adam_van
Member
212
890
Nov 2024
Vancouver, CA
Jun 28, 2025 at 5:52 AM#11
DeniseRN_TPA said:
PK/PD modeling for the pharmacology: understanding the pharmacokinetics helps optimize dosing.

Genuinely useful, thank you. I had the facts and not the framework. Adding it to my notes with a link back to this thread.

Last edited: Jun 28, 2025 at 9:52 AM
22 20FranDenver, Dr.BariatricHTX, LindaRN_retired and 19 others
Reply Quote Save Share Report
pat_auckland
Member
345
1,567
Jun 2024
Auckland, NZ
Jun 29, 2025 at 11:46 AM#12

Clinical perspective, offered as context rather than as advice. The mechanism and the magnitude are separate questions. Agreeing that something happens says nothing about whether it happens enough to act on.

That is the short version; the long version is somebody else's post.

Last edited: Jun 29, 2025 at 3:46 PM
23 21wanda_boise, NurseAsh_DET, BenResearch_OR and 20 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Jun 30, 2025 at 5:41 PM#13
SleepDoc_PDX said:
I want to add the drug interaction perspective on the pharmacology.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

24 22tony_orlando, Dr.NephBHM_UK, kim_atl_prep and 21 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
NicoleRaleigh
Member
356
1,567
Aug 2024
Raleigh, NC
Jul 1, 2025 at 11:37 PM#14

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Jul 2, 2025 at 12:37 AM
25 23VendorMark, COA_Karl, MikeFit_NJ and 22 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jul 3, 2025 at 5:33 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful. Tagging this one for the weekly digest.

26 24PurityPaulOR, MaxMetOK, MounjBrad and 23 others
Reply Quote Save Share Report

Similar Threads

GLP-1R desensitization — β-arrestin-mediated internalization18 replies
Biased agonism at GLP-1R — Gs vs β-arrestin signaling balance13 replies
Semaglutide albumin binding and the C-18 fatty acid linker17 replies
GIP receptor pharmacology — why GIP agonism enhances GLP-113 replies
Glucagon receptor signaling — hepatic glycogenolysis and lipolysis16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register